News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
139 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Policy
Ousted Arcturus Founder and CEO Claims He was Improperly Pushed Out by 4 Board Members
Joseph E. Payne was shown the door as CEO of Arcturus last week - a move that Payne is not taking lightly.
February 7, 2018
·
2 min read
·
Alex Keown
Deals
Cambridge’s Enumeral Filed for Bankruptcy, Sells Assets to Bay Area’s XOMA
It’s the end of the road for Cambridge, MA based Enumeral Biomedical.
February 7, 2018
·
2 min read
·
Alex Keown
FDA
Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy
The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy.
February 7, 2018
·
2 min read
·
Mark Terry
Business
J&J Gambles $1B on Theravance and Its GI Pipeline
J&J inked a global collaboration deal with Theravance Biopharma to develop a drug for IBD.
February 7, 2018
·
2 min read
·
Mark Terry
Policy
Another Day, Another Breakthrough Tag for GlaxoSmithKline’s Bexsero
Bexsero is the first vaccine in the world to receive the designation twice.
February 7, 2018
·
2 min read
·
Alex Keown
Biotech Bay
2 Bay Area Biotechs That Jumped While Its Peers Cratered
Since Friday, the stock market has been volatile, to say the least.
February 7, 2018
·
2 min read
·
Mark Terry
Drug Development
GlaxoSmithKline’s Booming Pipeline Under CEO Emma Walmsley
Since Emma Walmsley took over leadership at Glaxo, expectations have been both high and hypercritical.
February 7, 2018
·
3 min read
·
Mark Terry
Policy
J&J’s Ethicon Accuses Intuitive Surgical of Infringing Patents With the Endowrist Cutter-Stapler
The June 30, 2017 lawsuit asserts that the EndoWrist violates seven Ethicon patents.
February 7, 2018
·
1 min read
Policy
Titan Medical Pushes FDA Submission of Its Sport Single-Port Robotic Surgery Platform Back to 2019
The company expected a submission date in late 2018.
February 7, 2018
·
1 min read
BioMidwest
Why Exact Sciences Could Be a Millionaire-Maker Stock
The opportunities for this DNA test maker are tremendous. But there are challenges, also.
February 7, 2018
·
1 min read
1 of 14
Next
